BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25340554)

  • 1. The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.
    Matsuo R; Morihara H; Mohri T; Murasawa S; Takewaki K; Nakayama H; Maeda M; Fujio Y
    PLoS One; 2014; 9(10):e111097. PubMed ID: 25340554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
    Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
    Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
    Kurdi M; Booz GW
    J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
    Fischer P; Hilfiker-Kleiner D
    Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
    Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
    Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gp130/STAT3 signaling pathway mediates beta-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes.
    Zhang H; Feng W; Liao W; Ma X; Han Q; Zhang Y
    FEBS J; 2008 Jul; 275(14):3590-7. PubMed ID: 18537819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells.
    Ponce NE; Carrera-Silva EA; Pellegrini AV; Cazorla SI; Malchiodi EL; Lima AP; Gea S; Aoki MP
    Biochim Biophys Acta; 2013 Mar; 1832(3):485-94. PubMed ID: 23253440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
    Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
    Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.
    Waetzig GH; Chalaris A; Rosenstiel P; Suthaus J; Holland C; Karl N; Vallés Uriarte L; Till A; Scheller J; Grötzinger J; Schreiber S; Rose-John S; Seegert D
    J Biol Chem; 2010 Jan; 285(3):1781-9. PubMed ID: 19915009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.
    Fang XX; Jiang XL; Han XH; Peng YP; Qiu YH
    Cell Mol Neurobiol; 2013 Mar; 33(2):241-51. PubMed ID: 23161148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes.
    Hagiwara Y; Miyoshi S; Fukuda K; Nishiyama N; Ikegami Y; Tanimoto K; Murata M; Takahashi E; Shimoda K; Hirano T; Mitamura H; Ogawa S
    J Mol Cell Cardiol; 2007 Dec; 43(6):710-6. PubMed ID: 17961593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells.
    Sreenivasan L; Li LV; Leclair P; Lim CJ
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes.
    Fujio Y; Matsuda T; Oshima Y; Maeda M; Mohri T; Ito T; Takatani T; Hirata M; Nakaoka Y; Kimura R; Kishimoto T; Azuma J
    FEBS Lett; 2004 Aug; 573(1-3):202-6. PubMed ID: 15327998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
    Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
    Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.
    Arulanandam R; Geletu M; Feracci H; Raptis L
    Exp Cell Res; 2010 Mar; 316(5):875-86. PubMed ID: 19852956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes.
    Oh H; Fujio Y; Kunisada K; Hirota H; Matsui H; Kishimoto T; Yamauchi-Takihara K
    J Biol Chem; 1998 Apr; 273(16):9703-10. PubMed ID: 9545305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine.
    Kimura R; Maeda M; Arita A; Oshima Y; Obana M; Ito T; Yamamoto Y; Mohri T; Kishimoto T; Kawase I; Fujio Y; Azuma J
    Cytokine; 2007 May; 38(2):107-15. PubMed ID: 17629706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
    Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.